Indivior is a specialty pharmaceutical company focused on treatments for opioid use disorder and the broader science of addiction medicine. In the Canadian market, the company is associated with evidence-based therapies for recovery support, including buprenorphine-based treatment options used as part of structured care plans.
Addiction medicine, opioid use disorder therapeutics, specialty pharmaceuticals, central nervous system therapeutics, recovery-focused treatment, and evidence-based pharmaceutical care.
Opioid use disorder treatment products, including buprenorphine-based therapies such as SUBLOCADE, and related addiction treatment support programs.